IL2 and diabetes mellitus: We have previously measured the systemic plasma levels of pro-inflammatory cytokines (IL-2, IFNγ and TNFα) in these individuals and shown that IL-2, IFNγ and TNFα were significantly enhanced in active TB patients with DM compared to TB patients without DM [19].